Drugs / ZK 30595
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00653614 | Mar 2008 → Jun 2009 | — | Bayer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZK 30595 | “DRSP (ZK 30595) dose 1 (SH T04984F)” NCT00653614 ↗ |
| Known as | DRSP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00653614 ↗ |
| Route | Oral | “Single dose administration of DRSP as a tablet” NCT00653614 ↗ |